Publications by authors named "Peter Bugelski"

Claim this Profile
I
Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
Jason Aligo, Mindi Walker, Peter Bugelski, Daniel Weinstock

J Immunotoxicol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.
David J Shealy, Ann Cai, Kim Staquet, Audrey Baker, Eilyn R Lacy, Peter J Bugelski

MAbs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering peptide therapeutics using MIMETIBODY™ technology.
Kristen Picha, Chichi Huang, Peter Bugelski, Karyn O'Neil

Methods Mol Biol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia.
Dorie A Makropoulos, Ram Achuthanandam, Justin Avery, Krista Wilson, Kerry Brosnan, Peter J Bugelski

Curr Pharm Biotechnol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice.
Linda H Wu, C Chris Huang, Sree Adhikarakunnathu, Lani R San Mateo, Karen E Duffy, Peter Bugelski

Metabolism· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.
Peter J Bugelski, Pauline L Martin

Br J Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.
Pauline L Martin, Peter J Bugelski

Br J Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice.
Patricia Rafferty, Devon Egenolf, Kerry Brosnan, Dorie Makropoulos, Jarrat Jordan, Peter J Bugelski

J Immunotoxicol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis.
Mindi R Walker, Dorie A Makropoulos, Ram Achuthanandam, Scott Van Arsdell, Peter J Bugelski

Int Immunopharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetes.
Michael S Scully, Tatiana A Ort, Ian E James, Peter J Bugelski, Dorie A Makropoulos

Exp Diabetes Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a murine model of lymph node metastases suitable for immunotoxicity studies.
Devon D Egenolf, Patricia Rafferty, Kerry Brosnan, Mindi Walker, Jarrat Jordan, Peter J Bugelski

J Pharmacol Toxicol Methods· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia.
Peter J Bugelski, Amy Volk, Mindi R Walker, John H Krayer, Pauline Martin

Int J Toxicol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of CNTO 530, an erythropoietin mimetic-IgG4 fusion protein, on embryofetal development in rats and rabbits.
Pauline L Martin, Clifford Sachs, Alan Hoberman, Qun Jiao, Peter J Bugelski

Birth Defects Res B Dev Reprod Toxicol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the understanding of drug-mediated infusion reactions and cytokine release syndrome.
Mindi Walker, Dorie Makropoulos, Ram Achuthanandam, Peter J Bugelski

Curr Opin Drug Discov Devel· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody-induced cytokine-release syndrome.
Peter J Bugelski, Ram Achuthanandam, Renold J Capocasale, George Treacy, Esther Bouman-Thio

Expert Rev Clin Immunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice.
Nicole C Stowell, Jonathan Seideman, Holly A Raymond, Karen A Smalley, Roberta J Lamb, Peter J Bugelski

Respir Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools.
Pradeep Sathyanarayana, Estelle Houde, Deborah Marshall, Amy Volk, Dorie Makropoulos, Peter J Bugelski

Blood· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential univariate gating approach to study the effects of erythropoietin in murine bone marrow.
Ram Achuthanandam, John Quinn, Renold J Capocasale, Peter J Bugelski, Leonid Hrebien

Cytometry A· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of recombinant human erythropoietin in murine bone marrow.
Peter J Bugelski, Thomas Nesspor, Amy Volk, Joanne O'Brien, Dorie Makropoulos

Pharm Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
Renold J Capocasale, Dorie A Makropoulos, Ram Achuthanandam, Nicole Stowell, John Quinn, Peter J Bugelski

Cytometry A· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells and beyond: therapeutic opportunities targeting inflammation.
Bailin Liang, Ashlyn Eaton-Bassiri, Peter J Bugelski

Inflamm Allergy Drug Targets· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
John Quinn, Paul W Fisher, Renold J Capocasale, Ram Achuthanandam, Moshe Kam, Peter J Bugelski

Cytometry A· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model.
Dora M Berman, Over Cabrera, Norman M Kenyon, Joshua Miller, Susan H Tam, Peter J Bugelski

Transplantation· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-dependent antigen response (TDAR) tests: meta-analysis of results generated across multiple laboratories.
Peter J Bugelski, Carin Kim

J Immunotoxicol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Bailin Liang, Debra B Gardner, Don E Griswold, Peter J Bugelski, Xiao Yu R Song

Immunology· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis